Cigna Q2 Revenue Hits $71.7B, Raises 2026 EPS Outlook to $30.45+
CI sits 22% above its 52-week low of $239.51.
Summary
Cigna delivered a strong Q2 with revenue up 7% to $71.7 billion and adjusted EPS of $7.78, beating the year-ago $7.20. The company raised its full-year 2026 adjusted EPS outlook to at least $30.45, signaling confidence in sustained momentum. Growth was broad-based across Evernorth and Cigna Healthcare, while operating efficiency improved with SG&A ratio dropping to 4.6%. Medical customers grew 2% year-to-date, offsetting expected pharmacy client transitions. This follows a solid Q1 and recent strategic moves including the GLP-1 coverage change for employees and the Express Scripts lawsuit to protect specialty pharmacy access.
Updates
· Dow Jones Newswires — Healthcare unit pretax adjusted operating income rose 17%, with medical care ratio at 84.5% vs 83.2% a year ago.
At the time of this announcement, CI was trading at $291.88 on NYSE in the Life Sciences sector, with a market capitalization of approximately $78.4B. The 52-week trading range was $239.51 to $315.47. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.